Pcsk9 inhibitor market to reach $8.28 billion by 2030 at 20.6% cagr, driven by increasing hyperlipidemia prevalence.
Read More
The global parenteral nutrition market to reach $9.49 billion by 2030 at 6.0% cagr, driven by increasing birth rate.
Read More
The global parathyroid hormone market to reach $4.4 billion by 2030 at 11.9% cagr, driven by increasing geriatric population.
Read More
Parathyroid disease treatment market to reach $3.31 billion by 2030 at 6.8% cagr, driven by rising prevalence of chronic kidney disease.
Read More
Pancreatic cancer precision medicine market to reach $1.24 billion by 2030 at 16.6% cagr, driven by rising prevalence of pancreatic cancer.
Read More
Pancreatic cancer drugs market to reach $4.88 billion by 2030 at 3.9% cagr, driven by government initiatives and funding for pancreatic cancer research.
Read More
Pain management drugs market to reach $108.86 billion by 2030 at 5.1% cagr, driven by rise in the geriatric population globally.
Read More
Pain management market to reach $96 billion by 2030 at 4.4% cagr, driven by rising prevalence of chronic pain conditions across populations.
Read More
Paclitaxel injection market to reach $12.72 billion by 2030 at 13.4% cagr, driven by growing incidence of breast cancer and overall cancer cases.
Read More
Oxycodone hydrochloride market to reach $5.18 billion by 2030 at 3.6% cagr, driven by increasing prevalence of chronic pain worldwide.
Read More